Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies

Immune cell engagers are engineered antibodies with at least one arm binding a tumor-associated antigen and at least another one directed against an activating receptor in immune effector cells: CD3 for recrui...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Tags: Review Source Type: research